Zobrazeno 1 - 10
of 44
pro vyhledávání: '"Herbert Wachtel"'
Publikováno v:
Pulmonary Therapy, Vol 10, Iss 1, Pp 109-122 (2024)
Abstract Introduction The selection of inhaler device is of critical importance in chronic obstructive pulmonary disease (COPD) as the interaction between a patient’s inhalation profile and the aerosol characteristics of an inhaler can affect drug
Externí odkaz:
https://doaj.org/article/832681727c5c44aeb48ec95bd5e0d15e
Autor:
Ann-Cathrin Willmann, Kai Berkenfeld, Thilo Faber, Herbert Wachtel, Georg Boeck, Karl G. Wagner
Publikováno v:
Pharmaceutics, Vol 14, Iss 8, p 1528 (2022)
Nanocrystal suspensions proved to be a potent enabling principle for biopharmaceutics classification system class II drugs with dissolution limited bioavailability. In the example of itraconazole (ITZ) as a model drug combined with electrosteric stab
Externí odkaz:
https://doaj.org/article/289b207588534f169dfcc8136745e571
Publikováno v:
COPD: Journal of Chronic Obstructive Pulmonary Disease. 18:91-100
Tiotropium and olodaterol are mainstay treatments for chronic obstructive pulmonary disease (COPD) and yield important clinical improvements, especially when used in fixed-dose combination. Whilst previous studies have shown consistent delivery of ti
Autor:
Jennifer Quint, Jukka Montonen, Dave Singh, Herbert Wachtel, Sharon Attick, Swetha Palli, Monica Frazer, Vincent Willey, Glenn Giessel
Publikováno v:
Expert review of respiratory medicine. 16(4)
Discordance between real-world prescribing patterns and global treatment guidelines for the treatment of chronic obstructive pulmonary disease (COPD) with inhaled single or dual long-acting bronchodilator maintenance therapy is increasingly being rep
Publikováno v:
Journal of aerosol medicine and pulmonary drug delivery. 35(2)
The use of extrathoracic airway replicas in optimization of drug delivery to the lungs with nebulizers, dry powder inhalers (DPIs) and pressurized metered-dose inhalers (pMDIs) is discussed. Such airway replicas have been useful in evaluating new pul
Publikováno v:
J Pharm Technol
Objective: To review the role of pharmacists in educating and monitoring patients with chronic obstructive pulmonary disease (COPD) on inhalation technique. Data Sources: A PubMed search (January 2000 to May 2020) was performed using the following ke
Publikováno v:
Advances in Therapy. 36:2487-2492
Pressurised metered-dose inhalers (pMDIs) are associated with global warming potential values as they contain a hydrofluoroalkane (HFA) propellant, whereas the Respimat® Soft Mist™ inhaler is propellant-free. The original disposable Respimat has r
Publikováno v:
Computers in Biology and Medicine. 107:206-217
This work describes the development of an idealized geometry that mimics average regional deposition of nasal sprays within realistic adult nasal geometries. Previous simulation results in seven realistic nasal airways (Kiaee et al. Int. J. Num. Meth
Autor:
Martin Meisenheimer, Ingeborg Jost, Rajiv Dhand, Herbert Wachtel, Michaela Hänsel, Joachim Eicher
Publikováno v:
International Journal of Chronic Obstructive Pulmonary Disease. 14:509-523
Purpose The Respimat is a handheld, propellant-free, soft-mist inhaler. Observations by patients and physicians prompted development of an improved second-generation Respimat inhaler. Human-factor studies assessing the usability of the new inhaler an
Publikováno v:
Chest. 160:A1861-A1862